(Q46888766)

26 December 2017

title

ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy (English)

1 reference

26 December 2017

1 reference

5

1 reference

26 December 2017

Nicola Fazio

7

1 reference

26 December 2017

author name string

Sara De Dosso

1

1 reference

26 December 2017

Elena Zanellato

2

1 reference

26 December 2017

Martina Nucifora

3

1 reference

26 December 2017

Renzo Boldorini

4

1 reference

26 December 2017

Roberto Biffi

6

1 reference

26 December 2017

Eraldo Bucci

8

1 reference

26 December 2017

Ottavio Beretta

9

1 reference

26 December 2017

Stefano Crippa

10

1 reference

26 December 2017

Piercarlo Saletti

11

1 reference

26 December 2017

Milo Frattini

12

1 reference

26 December 2017

publication date

5 May 2013

1 reference

26 December 2017

Cancer Chemotherapy and Pharmacology

published in

1 reference

26 December 2017

volume

72

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

159-165

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1007/s00280-013-2181-2

exact match

0 references

cites work

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Multimodality treatment for localized gastro-oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Molecular predictors of response to chemotherapy in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

ERCC1 and clinical resistance to platinum-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Increased ERCC expression correlates with improved outcome of patients treated with cisplatin as an adjuvant therapy for curatively resected gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Thymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouracil-based adjuvant chemotherapy for gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Angiogenesis and apoptosis-related protein (p53, bcl-2, and bax) expression versus response of gastric adenocarcinomas to paclitaxel and carboplatin chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

TP53, p14ARF, p16INK4a and H-ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2181-2

10.1007/S00280-013-2181-2

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

23645290

1 reference

26 December 2017